2 completed, 1 recruiting, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow Frisius Medisch Centrum: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pregnancy Outcomes: Effects of Metformin Study (POEM Study) Metformin TEVA 850 mg - Gestational Diabetes, Insulin Resistance | Phase 3 | Recruiting | Bethesda Diabetes Research Center | 500 | 2019-11-26 | 2022-02-10 |
| The Effect of Ketanserin on the Microcirculation in Sepsis ketanserin - Severe Sepsis, Septic Shock | Phase 3 | Completed | Frisius Medisch Centrum | 10 | 2011-03-01 | 2014-05-09 |
| The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis nitroglycerin iv, placebo = nacl 0.9% - Sepsis, Septic Shock | Phase 3 | Completed | Frisius Medisch Centrum | 70 | 2007-06-01 | 2008-07-16 |
| Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients Furosemide - Renal Failure, Critically Ill | Phase 3 | Terminated | Frisius Medisch Centrum | 72 | 2005-12-01 | 2007-04-19 |
Sepsis (2) · Shock, Septic (2) · Critical Illness (1) · Diabetes, Gestational (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Renal Insufficiency (1)
Furosemide (1) · Ketanserin (1) · Metformin (1) · Sodium Chloride (1)
Netherlands (4)
Adriaan Kooy, Dr. (1) · E Boerma, MDPhD (1) · E C Boerma, MD (1) · Peter van der Voort, MD, PhD, MSc (1)